Lee's Pharmaceutical Holdings Limited (FRA:L1PA)
Germany flag Germany · Delayed Price · Currency is EUR
0.1600
+0.0060 (3.90%)
Last updated: Jan 28, 2026, 9:55 AM CET

FRA:L1PA Balance Sheet

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
303.58216.85171189.3277.53375.2
Short-Term Investments
-----39.34
Cash & Short-Term Investments
303.58216.85171189.3277.53414.54
Cash Growth
55.69%26.81%-9.67%-31.79%-33.05%-46.52%
Accounts Receivable
185.85161.184.59111.28168.32159.57
Other Receivables
88.9845.4545.41-23.34-
Receivables
274.83206.55130111.28191.66237.08
Inventory
282.79287.51298.11249.22331.39414.38
Prepaid Expenses
-4.657.5853.8859.769.98
Other Current Assets
-69.0349.9447.95103.04103.13
Total Current Assets
861.2784.59656.63651.63963.321,239
Property, Plant & Equipment
393.98400.59443.37540.67688.27724.55
Long-Term Investments
479.99285.21699.45554.751,043421.69
Goodwill
4.374.374.373.93.93.9
Other Intangible Assets
1,246311.63282.36293.75302.26286.47
Long-Term Deferred Tax Assets
11.018.110.27.5815.4218.73
Long-Term Deferred Charges
-823.39794.29729.74620.26558.49
Total Assets
2,9962,6182,8912,7823,6373,253
Accounts Payable
133.03141.9774.15101.362.673.73
Accrued Expenses
-----55.42
Short-Term Debt
46.9142.3225.39-12.26141.38
Current Portion of Long-Term Debt
100.57107.6496.7376.73150.28-
Current Portion of Leases
9.037.87.456.8312.647.83
Current Income Taxes Payable
11.938.776.083.060.1329.92
Current Unearned Revenue
-----135.13
Other Current Liabilities
511.92462.76439.02462.18684.67500.65
Total Current Liabilities
813.39771.25648.82650.1922.58944.05
Long-Term Debt
82.7663.9170.6477.3684.09-
Long-Term Leases
4.365.633.932.577.877.5
Pension & Post-Retirement Benefits
129.79122.79110.196.23111.97104
Long-Term Deferred Tax Liabilities
94.4284.2373.4373.979.2381.99
Other Long-Term Liabilities
48.1121.1523.1539.3440-
Total Liabilities
1,1731,069930.07939.51,2461,138
Common Stock
29.4429.4429.4429.4429.4429.41
Additional Paid-In Capital
720.09720.09720.09720.09720.09714.81
Retained Earnings
3,6993,6423,5613,5443,5111,559
Comprehensive Income & Other
-2,505-2,739-2,271-2,369-1,796-153.72
Total Common Equity
1,9431,6522,0391,9242,4652,150
Minority Interest
-120.05-102.89-78.36-81.58-73.42-34.42
Shareholders' Equity
1,8231,5491,9611,8432,3912,115
Total Liabilities & Equity
2,9962,6182,8912,7823,6373,253
Total Debt
243.63227.3204.14163.49267.14156.71
Net Cash (Debt)
59.95-10.45-33.1425.8110.39257.83
Net Cash Growth
---148.36%-95.97%-57.54%
Net Cash Per Share
0.10-0.02-0.060.040.020.44
Filing Date Shares Outstanding
588.84588.84588.84588.84588.84588.13
Total Common Shares Outstanding
588.84588.84588.84588.84588.84588.13
Working Capital
47.813.337.811.5340.74295.05
Book Value Per Share
3.302.813.463.274.193.66
Tangible Book Value
693.391,3361,7521,6262,1581,859
Tangible Book Value Per Share
1.182.272.982.763.673.16
Buildings
-217.54225.35232.29259.65258.5
Machinery
-571.77561.37548.42572.66521.86
Construction In Progress
-24.1824.7838.6252.5752.18
Leasehold Improvements
-71.4675.6975.758165.91
Source: S&P Global Market Intelligence. Standard template. Financial Sources.